We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
The latest trading session saw Walgreens Boots Alliance (WBA - Free Report) ending at $9.02, denoting a -0.44% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.56%. Elsewhere, the Dow gained 0.42%, while the tech-heavy Nasdaq added 0.83%.
The the stock of largest U.S. drugstore chain has fallen by 4.23% in the past month, lagging the Retail-Wholesale sector's gain of 5.95% and the S&P 500's gain of 3.11%.
The investment community will be paying close attention to the earnings performance of Walgreens Boots Alliance in its upcoming release. The company's upcoming EPS is projected at $0.38, signifying a 42.42% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $37.2 billion, up 1.35% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.53 per share and revenue of $149.06 billion. These totals would mark changes of -46.88% and +0.95%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Walgreens Boots Alliance. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 1.04% lower. Walgreens Boots Alliance is holding a Zacks Rank of #3 (Hold) right now.
Looking at valuation, Walgreens Boots Alliance is presently trading at a Forward P/E ratio of 5.94. This represents no noticeable deviation compared to its industry's average Forward P/E of 5.94.
One should further note that WBA currently holds a PEG ratio of 1.19. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. WBA's industry had an average PEG ratio of 1.02 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 229, finds itself in the bottom 10% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
The latest trading session saw Walgreens Boots Alliance (WBA - Free Report) ending at $9.02, denoting a -0.44% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.56%. Elsewhere, the Dow gained 0.42%, while the tech-heavy Nasdaq added 0.83%.
The the stock of largest U.S. drugstore chain has fallen by 4.23% in the past month, lagging the Retail-Wholesale sector's gain of 5.95% and the S&P 500's gain of 3.11%.
The investment community will be paying close attention to the earnings performance of Walgreens Boots Alliance in its upcoming release. The company's upcoming EPS is projected at $0.38, signifying a 42.42% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $37.2 billion, up 1.35% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.53 per share and revenue of $149.06 billion. These totals would mark changes of -46.88% and +0.95%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Walgreens Boots Alliance. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 1.04% lower. Walgreens Boots Alliance is holding a Zacks Rank of #3 (Hold) right now.
Looking at valuation, Walgreens Boots Alliance is presently trading at a Forward P/E ratio of 5.94. This represents no noticeable deviation compared to its industry's average Forward P/E of 5.94.
One should further note that WBA currently holds a PEG ratio of 1.19. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. WBA's industry had an average PEG ratio of 1.02 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 229, finds itself in the bottom 10% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.